Back to search

Article

ELOVL2, a novel and potential tumor antigen guided mRNA vaccine development for retroperitoneal liposarcoma

2023-03-17

Abstract excerpt

<h4>Background: </h4> The exploration of lipid metabolism dysregulation may provide novel perspectives for retroperitoneal liposarcoma (RPLS). In our study, we aimed to investigate potential tumor antigen for mRNA vaccine development and facilitate further understanding of immune landscape in RPLS, through lipid metabolism-associated genes (LMAGs) based prognostic model. Methods Gene expression profiles and corre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
efa004f8-9d18-5bc3-aa6c-b1306d43815e
DOI
10.21203/rs.3.rs-2688489/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ELOVL2, a novel and potential tumor antigen guided mRNA vaccine development for retroperitoneal liposarcomaDOI 10.21203/rs.3.rs-2688489/v1
Select a neighboring publication to make it the new centre.